title: Capillary electrophoresis-mass spectrometry-based detection of drugs and neurotransmitters in Drosophila brain.
abstract: Capillary electrophoresis coupled to mass spectrometry has been used to determine the in vivo concentrations of the neuroactive drug, methylphenidate, and a metabolite in the heads of the fruit fly, Drosophila melanogaster . These concentrations, evaluated at the site of action, the brain, have been correlated with orally administrated methylphenidate. D. melanogaster has a relatively simple nervous system but possesses high-order brain functions similar to humans; thus, it has been used as a common model system in biological and genetics research. Methylphenidate has been used to mediate cocaine addiction due to its lower pharmacokinetics, which results in fewer addictive and reinforcing effects than cocaine; the effects of the drug on the nervous system, however, have not been fully understood. In addition to measurements of drug concentration, the method has been used to examine drug-dose dependence on the levels of several primary biogenic amines. Higher in vivo concentration of methylphenidate is observed with increasing feeding doses up to 25 mM methylphenidate. Furthermore, administrated methylphenidate increases the drug metabolism activity and the neurotransmitter levels; however, this increase appears to saturate at a feeding dose of 20 mM. The method developed for the fruit fly provides a new tool to evaluate the concentration of administered drug at the site of action and provides information concerning the effect of methylphenidate on the nervous system.
authors.affiliation: Department of Chemistry and Molecular Biology, University of Gothenburg, Kemivägen 10, SE-412 96 Gothenburg, Sweden.
authors.forename: Nhu T N
authors.initials: NT
authors.lastname: Phan
authors.forename: Jörg
authors.initials: J
authors.lastname: Hanrieder
authors.forename: E Carina
authors.initials: EC
authors.lastname: Berglund
authors.forename: Andrew G
authors.initials: AG
authors.lastname: Ewing
mesh_terms: D000818:Animals; D030801:Animals, Genetically Modified; D001923:Brain Chemistry; D004330:Drosophila; D019075:Electrophoresis, Capillary / Q000379:methods; D008297:Male; D018377:Neurotransmitter Agents / Q000032:analysis*; D004364:Pharmaceutical Preparations / Q000032:analysis*; D021241:Spectrometry, Mass, Electrospray Ionization / Q000379:methods*
chemical_list: D018377:Neurotransmitter Agents; D004364:Pharmaceutical Preparations
references.citation: Pharmacol Biochem Behav. 2006 Sep;85(1):29-38
references.pmid: 16916538
references.citation: Br J Clin Pharmacol. 1979 Dec;8(6):571-6
references.pmid: 533578
references.citation: Drug Metab Dispos. 2000 Jun;28(6):620-4
references.pmid: 10820132
references.citation: Biosci Biotechnol Biochem. 2000 Dec;64(12):2625-30
references.pmid: 11210126
references.citation: Anal Chem. 2003 Aug 15;75(16):3972-8
references.pmid: 14632107
references.citation: Biochem Genet. 1997 Apr;35(3-4):91-103
references.pmid: 9241434
references.citation: Anal Chem. 2011 Mar 15;83(6):2258-64
references.pmid: 21322586
references.citation: ACS Chem Neurosci. 2010 Jan 20;1(1):74-83
references.pmid: 20352129
references.citation: Drug Metab Dispos. 1981 Sep-Oct;9(5):415-23
references.pmid: 6117439
references.citation: J Comp Physiol B. 2002 Oct;172(7):643-50
references.pmid: 12355233
references.citation: J Pharmacol Exp Ther. 1974 Dec;191(3):535-47
references.pmid: 4473537
references.citation: Rapid Commun Mass Spectrom. 2011 Sep 15;25(17):2397-406
references.pmid: 21910286
references.citation: J Med Chem. 1981 Oct;24(10):1237-40
references.pmid: 7328584
references.citation: Pharmacol Biochem Behav. 2001 Mar;68(3):611-27
references.pmid: 11325419
references.citation: J Pharm Sci. 1999 Aug;88(8):754-8
references.pmid: 10430537
references.citation: Anal Chem. 2008 Feb 15;80(4):1201-7
references.pmid: 18193891
references.citation: Drugs. 2004;64(14):1547-73
references.pmid: 15233592
references.citation: Electrophoresis. 2004 Oct;25(20):3427-33
references.pmid: 15490449
references.citation: J Chromatogr A. 1999 Aug 20;853(1-2):527-33
references.pmid: 10486762
references.citation: Metabolomics. 2013 Apr 1;9(2):392-402
references.pmid: 23554582
references.citation: J Neurosci. 2002 Aug 15;22(16):7264-71
references.pmid: 12177221
references.citation: Curr Biol. 1999 Aug 26;9(16):853-60
references.pmid: 10469593
references.citation: ACS Chem Neurosci. 2013 Apr 17;4(4):566-74
references.pmid: 23402315
references.citation: Arch Gen Psychiatry. 1995 Jun;52(6):456-63
references.pmid: 7771915
references.citation: J Pharmacol Exp Ther. 1983 Aug;226(2):382-6
references.pmid: 6410043
references.citation: Nat Neurosci. 1998 Jun;1(2):132-7
references.pmid: 10195128
references.citation: Addict Biol. 2012 Sep;17(5):887-96
references.pmid: 21762288
references.citation: Proc Natl Acad Sci U S A. 1998 Jun 23;95(13):7699-704
references.pmid: 9636213